y.erdogan
Submits third-party assay reports on material purchased directly. Based in Izmir.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.11%
n=9
Suppliers covered
9
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041385 | BPC-157 | WWB | WWB-2606-H3906 | Medutest | 2026-Q3 | 99.29 | 4.43 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043533 | Leuprolide | WXT | WXT-2604-K4483 | PeptideMeter | 2026-Q3 | 99.89 | 4.94 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041707 | CJC-1295 (no DAC) | QSC | QSC-2606-V8267 | Janoshik | 2026-Q3 | 99.93 | 3.74 | 100.2 | Buyer-sourced | 0 | PASS |
| AX-2026-042883 | Semaglutide | GGPeps | GGPE-2604-L1855 | Janoshik | 2026-Q2 | 99.11 | 5.52 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042080 | L-Glutathione (reduced) | JEEP | JEEP-2510-S6399 | Janoshik | 2026-Q1 | 99.45 | 7.24 | 104.8 | Laboratory-retained | 0 | PASS |
| AX-2026-043295 | KPV | SSA | SSA-2507-B8786 | VendorInvestigate | 2025-Q4 | 98.63 | 4.37 | 96.8 | Buyer-sourced | 0 | FAIL |
| AX-2025-019203 | Survodutide | HYB | HYB-2504-X5304 | Nordanalyt | 2025-Q3 | 98.73 | 4.33 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020885 | Tirzepatide | SGN | SGN-2507-W1865 | Janoshik | 2025-Q3 | 98.05 | 5.78 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2024-004737 | Tirzepatide | TFC | TFC-2405-W8094 | Janoshik | 2024-Q2 | 97.88 | 5.40 | — | Buyer-sourced | 0 | PASS |